AccessPak for HIV PEP Expanded with Kaletra and Danaparoid Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Danaparoid Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: danaparoid
Brand name:
Synonyms: Danaparoid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Danazol
- AccessPak for HIV PEP Expanded with Kaletra-Danocrine
- AccessPak for HIV PEP Expanded with Kaletra-Dantrium
- AccessPak for HIV PEP Expanded with Kaletra-Dantrium (Dantrolene Capsules)
- AccessPak for HIV PEP Expanded with Kaletra-Dantrium (Dantrolene Injection)
- AccessPak for HIV PEP Expanded with Kaletra-Dantrium Intravenous
- Danaparoid Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Danaparoid Subcutaneous-Accolate
- Danaparoid Subcutaneous-Accretropin
- Danaparoid Subcutaneous-Accucaine
- Danaparoid Subcutaneous-AccuHist Drops
- Danaparoid Subcutaneous-AccuHist PDX Drops